Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

JTC shares surge on bullish update, bolt-on acquisition

(Sharecast News) - JTC shares jumped 13% on Thursday after the professional services business reported a record first half for new business wins and announced the acquisition of trust and estate planning services firm Kleinwort Hambros Trust (KHT). The company, which offers fund, corporate and private client services, hailed a "resilient and sector-leading performance" in the first half of 2025, with net organic revenues up 10%.

New business wins totalled a record £19.5m, up from £18.8m the year before, with win rates above 50% and the new business pipeline up 10% since the start of the year.

Since the period-end, JTC announced the acquisition of Citi's global fiduciary and trust administration services business, formerly known as Citi Trust, which the company said on Thursday is expected to deliver within group margins by 2026 - 12 months earlier than expected.

In a separate announcement, JTC said its acquisition of KHT, from Swiss bank Union Bancaire Privée, is "highly complementary to JTC's existing private client services offering", strengthening its trust presence in the Channel Islands, adding a UK trust business for the first time.

Following the Citi Trust and KHT acquisitions, JTC's net debt equates to 2.2 times underlying EBITDA, though the company said it was prepared to accept leverage of up to 2.5x "for a short period, given the highly cash generative nature of the business".

The deals "further cement our position as the world's leading independent trust company and the partner of choice for banking institutions", said chief executive Nigel Le Quesne.

The stock was up 13% at 929p by 1107 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.